| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |